11C-labeling of busulphan.

Int J Rad Appl Instrum A

Karolinska Pharmacy, Stockholm, Sweden.

Published: June 1992

Busulphan [1,4-bis(methanesulfonoxy)butane], an alkylating agent used in the treatment of chronic myelocytic leukemia, was labeled with the positron-emitting radionuclide carbon-11 in a four-step synthetic procedure [1-11C]4-Hydroxybutyronitrile was obtained in 60-70% yield by the reaction of [11C]cyanide with 3-bromopropanol. The nitrile was hydrolysed to [1-11C]gamma-butyrolactone (80-90% yield) with sulfuric acid. Solid phase extraction was used to isolate the lactone and change the solvent before reduction to [1-11C]1,4-butanediol. Dimesylation of the diol with methanesulfonyl chloride in dichloromethane/pyridine yielded [1-11C]busulphan with conversions in the order of 30-35%. The total time of synthesis, including HPLC purification, was 65-75 min from the end-of-trapping of [11C]ammonium cyanide. The decay-corrected isolated yield of no-carrier-added [11C]busulphan was 4-7% and the radiochemical purity was better than 99%.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0883-2889(91)90010-xDOI Listing

Publication Analysis

Top Keywords

11c-labeling busulphan
4
busulphan busulphan
4
busulphan [14-bismethanesulfonoxybutane]
4
[14-bismethanesulfonoxybutane] alkylating
4
alkylating agent
4
agent treatment
4
treatment chronic
4
chronic myelocytic
4
myelocytic leukemia
4
leukemia labeled
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!